Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Fund Launch

18 Jun 2007 07:00

Braveheart Investment Group plc18 June 2007 18 June 2007 Braveheart Investment Group plc ("Braveheart", or "the Company") PARTNERSHIP WITH THE UNIVERSITY OF EDINBURGH TO CREATE £25 MILLION FUND Investing in commercial investment opportunities emanating from the University Braveheart (AIM: BRH), the technology commercialisation and investmentmanagement company, and the University of Edinburgh, Scotland's largestUniversity ("the University"), announce the creation of a dedicated £25 millionfund ("the Fund"), further extending the relationship between the two parties. With a maximum value of £25 million, the Fund will have rights of first refusalto invest in all commercial investment opportunities that arise in respect ofcompanies and intellectual property emanating from the University, other than inthe field of medicine, veterinary medicine and life sciences, where it may takea co-investment position. The Fund, which intends to generate attractive commercial rates of return forits investors, will seek financial commitments from a number of partners. It isanticipated that the first round of investment will close in the spring of 2008,and will involve cornerstone investors including Braveheart itself, theUniversity, Bank of Scotland and others. Braveheart will act as fund manager and will issue an information memorandum toprospective partners in early 2008. This is Braveheart's second such fund,following the announcement in February this year of the £12 million StrathclydeInnovation Fund partnership with the University of Strathclyde. In common with the Strathclyde fund, Braveheart will share 25% of itsperformance bonus with the University. In addition, when an investment is made,a payment will be made to the department which has sponsored the investmentopportunity, thereby encouraging departments within the University toparticipate in the commercialisation partnership. The Fund will have a life of eight years, comprising an investment period offive years followed by a period of three years in which to monitor and manageexisting investments. There are options to extend the life of the Fund, up to amaximum aggregate period of 10 years. Braveheart and the University's commercialisation arm, Edinburgh Research andInnovation will pool resources and expertise to help with the commercialisationof companies and their technologies. Braveheart will also use its network ofbusiness angel investors to provide non-executive directors to companies thatare spun-out, making crucial expert advice on corporate development available tothem. The University of Edinburgh is Scotland's largest University and is rated fifthin the UK and first in Scotland for research income. The University attractedresearch awards of £139 million in 2005/2006, including 23 awards in excess of£1 million. In 2005/2006, the University supported the formation of 23 new companies andbusinesses. Over the past five years, 57 companies have been created, of which91 per cent are still trading. These companies have raised around £18 million ininvestment funding and employ over 150 staff. Braveheart has a strong 10-year track record in the field of commercialisation,and has consistently produced annual rates of return for its investors thatexceed 35 per cent. To date, Braveheart has exited 17 of the companies it hasinvested in. Of these, six have been IPOs and three have been trade sales, withthe balance being write-offs. To date, three University of Edinburgh spin-out companies have developed intopublicly quoted companies. These are Vision Group plc, Wolfson Microelectronicsplc and MicroEmissive Displays Group plc. Both Wolfson and MicroEmissiveDisplays were in the Braveheart portfolio prior to them becoming publiccompanies. The Company also recently announced a £300,000 investment through itsAlpha EIS Fund into Spiral Gateway, a semi-conductor company which spun-out ofthe University. Commenting, Geoffrey Thomson, Chief Executive of Braveheart, said: "We have hada strong working relationship with the University since 2003, having supportedeight spin-out companies to date. The creation of the Edinburgh University fundwill act as a further catalyst to the successful commercialisation of theUniversity's intellectual property. The Fund is also a further opportunity forBraveheart to extend its ability to make proprietary investments following ourflotation in March this year. "This Fund offers access to capital for innovative intellectual propertyemanating from the University, to support it en route to commercialisation. Wehave successfully supported young companies for ten years now and we expect tofinance some really exciting technology with this fund. The University has awell deserved world class reputation for commercialisation and we are delightedthey wish to strengthen their relationship with us." Derek Waddell of the University of Edinburgh, said: "The University of Edinburghhas an integrated policy for, and a strong track record in, company formation.We provide high levels of support to staff and students who wish to create newcompanies and, on average, we produce one new company every month. We work hardto produce companies with a sound technology base and good managerial teams andlook forward to working with Braveheart to develop the Fund, which will not onlyoffer important early stage finance for these companies, but importantly alsoprovide our companies with access to experienced management expertise." For further information, contact: Braveheart Tavistock Communications University of EdinburghGeoffrey Thomson Richard Sunderland Derek WaddellChief Executive Rachel Drysdale Managing DierctorT: 01738 587 555 T: 020 7920 3150 Edinburgh Research and Innovation rdrysdale@tavistock.co.uk T: 0131 650 9040 About The University of Edinburgh • The University of Edinburgh was founded in 1583 and is the largestuniversity in Scotland with over 23,000 students from more than 120 differentcountries. In 2005, it was named the Sunday Times Scottish University of theYear and was described by the paper as "a model of broad and consistentexcellence". • The University of Edinburgh is recognised for its innovative researchacross a broad range of disciplines. Since the Scottish Enterprise Proof of Concept grant programme was initiated, atotal of 26 University of Edinburgh projects have received Proof of Conceptgrants, including four in the last year. In the past ten years, the Universityof Edinburgh and its network of spin-out and start-up companies havecollectively won 44 SMART awards. About Braveheart Braveheart is a technology commercialisation and investment management groupwith a proven track record of delivering attractive returns by makinginvestments in companies which commercialise intellectual property.Braveheart Ventures, which later became a subsidiary of Braveheart InvestmentGroup, was formed in 1997 by four Scottish businessmen as a co-investmentvehicle in order to pool their money and knowledge, increase diversification andreduce risk. Braveheart makes investments in young, emerging, unlisted companies where thereis potential for significant growth. Typically, Braveheart's investments arefocused on British companies with potential global technology solutions.However, the Group also maintains limited exposure to more traditionalbusinesses. Braveheart's portfolio ranges from start-up companies to companieswhich are close to an IPO or sale. Each year, out of several hundred businessplans received, around ten investments are made, all of which demonstrateattractive exit potential. These opportunities arise from Braveheart's networkof contacts, which includes close relationships with universities, innovationcentres, and the Group's own clients. The Group's business consists of two components:• an investment management business; and• direct investment. These components provide the Group with a mix of regular revenue streams,principally from investment management fees, and exceptional income through therealisation of investments upon exit. The Group's investment management business arranges and manages investments onbehalf of sophisticated private investors, corporate entities and public sectororganisations. Many clients are successful entrepreneurs in their own right andhave extensive track records of starting, building and exiting companies.Clients are able to choose whether they wish to be active investors (referred toas advisory clients) or passive investors (referred to as discretionaryclients). Advisory clients build their own portfolio based on opportunitiespresented by the Group. Discretionary clients give a mandate to the Group tobuild portfolios based upon agreed objectives. The Group currently has approximately 100 clients who, as well as investingfunds, frequently provide:• secondary pre-investment due diligence;• management skills and business development expertise;• a pool of executive and non-executive directors; and• further investment opportunities. Each client has a different portfolio and therefore a different overall return.An equal investment made in every portfolio company since the Group's formationwould have generated an average compound return of 37 per cent. per annum onrealised investments (these being investments where an exit has been achieved).Of the 17 realised investments, six have been by way of IPO, and three by way oftrade sale or secondary purchase. Eight have been written off. In November 2005, Uberior Investments plc (a subsidiary of the Bank of Scotland)subscribed for 10 per cent. of the enlarged capital of the Company. Thisprovided the resources for Braveheart to commence making significant directinvestments alongside its clients. As at 31 March 2007 there had been threerealisations of investments directly held by Braveheart which have togethergenerated a compound return of 110 per cent. per annum. The Group is based in Perth and has a staff of nine. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th May 202012:48 pmRNSHolding(s) in Company
11th May 20208:51 amRNSHolding(s) in Company
11th May 20207:01 amRNSHolding(s) in Company
11th May 20207:00 amRNSHolding(s) in Company
7th May 20206:15 pmRNSHolding(s) in Company
6th May 20207:00 amRNSUpdate in response to social media speculation
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:36 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFurther re Kirkstall Limited
1st May 20207:00 amRNSFurther Placing to raise £350,000
29th Apr 20204:40 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
29th Apr 20207:00 amRNSPlacing to raise £275,000
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
23rd Apr 20207:00 amRNSOperational update re certain investments
14th Apr 20207:00 amRNSOperational update on the Strategic Investments
3rd Mar 20207:00 amRNSOperational Update and Strategic Investments
30th Jan 20207:00 amRNSOperational update on Strategic Investments
12th Dec 20197:00 amRNSFurther investment in Pharm 2 Farm Limited
21st Nov 20197:00 amRNSOperational update on strategic investments
31st Oct 201910:55 amRNSHalf-year Report
28th Oct 20195:12 pmRNSFurther re buying remaining shares of Paraytec
19th Sep 20197:00 amRNSResults of customer trials by Pharm2Farm Limited
18th Sep 20197:00 amRNSDiscussions to buy remaining shares of Paraytec
29th Aug 201912:20 pmRNSResult of AGM
5th Aug 20197:00 amRNSPosting of annual accounts
1st Aug 20193:27 pmRNSREPLACEMENT: Final Results
1st Aug 20197:00 amRNSFinal Results
8th Jul 20197:00 amRNSInvestment in Pharm2Farm Limited
7th Jun 20197:00 amRNSUpdate to the Market
16th Apr 20197:00 amRNSDisposal of Viking Fund Managers Limited
12th Feb 201910:25 amRNSHolding(s) in Company
31st Jan 20195:17 pmRNSHolding(s) in Company
13th Dec 20187:00 amRNSFund Management Division Update
30th Oct 20187:00 amRNSInterim Results
18th Oct 201811:28 amRNSUpdate re Reduction of Share Capital
24th Sep 20189:00 amRNSConversion of Loan Notes in Paraytec Limited
4th Sep 20187:00 amRNSFurther re. Partial Disposal of Investment
21st Aug 20187:00 amRNSPartial Disposal of Investment in Gyrometric
19th Jul 201812:15 pmRNSResult of AGM and GM
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.